GAD-67 Antibodies

Santa Cruz Biotechnology delivers a wide array of GAD-67 monoclonal antibodies for research focused on understanding glutamic acid decarboxylase 67 (GAD-67) in various biological processes. GAD-67 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GAD-67 is a critical enzyme involved in the synthesis of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. Proper GAD-67 functioning is essential for maintaining the balance of excitatory and inhibitory signals in the brain, which is crucial for normal neurological function. Dysregulation of GAD-67 has been implicated in various neurological disorders, making it a significant target for research aimed at understanding and treating these conditions. GAD-67 monoclonal antibodies enable researchers to explore neural pathways and signaling mechanisms in the central nervous system. Investigating GAD-67 expression patterns and interactions provides valuable insights into neurotransmitter regulation and brain function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neuroscience and contributing to the development of therapeutic strategies for neurological disorders.